SLN.L Regulatory News (SLN)

30 Jun 2005 09:43

SR Pharma plcAnnual General Meeting StatementLondon 30 June 2005 - SR Pharma plc ("the Company") announces that at theAnnual General Meeting of the Company held earlier today, all resolutions werepassed.The passing of Resolutions 6 & 7 has given the Directors authority toissue Ordinary Shares up to an aggregate nominal amount of ‚£1,000,000, whichwill enable the Directors to complete the acquisition of Atugen AG, subject toshareholder approval at the Extraordinary General Meeting scheduled for 11 July2005, as set out in the Company circular to shareholders that was posted andannounced on 24 June 2005 and to undertake the fundraising that was describedin the same circular.Further informationMelvyn DaviesCompany SecretarySR Pharma plcTel: 020 7307 1620ENDSR PHARMA PLC